Role of immune-regulatory cells in skin pathology

Journal of Leukocyte Biology

Volumn 89, Issue 1, 2011, Pages 41-49

  Ilkovitch, Dan ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Burns; Cancer; Dermatitis; Myeloid derived suppressor cell; Psoriasis; Transplant; Treg

Indexed keywords

BURN; CELL EXPANSION; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CONTACT DERMATITIS; HUMAN; MAST CELL; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; SKIN ALLERGY; SKIN PATHOLOGY; SKIN TUMOR; SUPPRESSOR CELL;

ANIMALS; HUMANS; LEUKOCYTES; MODELS, IMMUNOLOGICAL; SKIN; SKIN DISEASES; SKIN TRANSPLANTATION;

EID: 79251584654     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0410229     Document Type: Review

References (134)

1. Bos, J. D., Kapsenberg, M. L. (1993) The skin immune system: progress in cutaneous biology. Immunol. Today 14, 75-78.
2. Romani, N., Clausen, B. E., Stoitzner, P. (2010) Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 234, 120-141.
3. Metz, M., Maurer, M. (2007) Mast cells - key effector cells in immune responses. Trends Immunol. 28, 234-241. (Pubitemid 46654869)
4. Jameson, J., Havran, W. L. (2007) Skin γδ T-cell functions in homeostasis and wound healing. Immunol. Rev. 215, 114-122. (Pubitemid 46212234)
5. Bos, J. D., Kapsenberg, M. L. (1986) The skin immune system. Its cellular constituents and their interactions. Immunol. Today 7, 235-240.
6. Nestle, F. O., Di Meglio, P., Qin, J. Z., Nickoloff, B. J. (2009) Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9, 679-691.
7. Kim, J. M., Rasmussen, J. P., Rudensky, A. Y. (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197.
8. Sakaguchi, S. (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
9. Davidson, T. S., DiPaolo, R. J., Andersson, J., Shevach, E. M. (2007) Cutting edge: IL-2 is essential for TGF-β-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 178, 4022-4026. (Pubitemid 46492349)
10. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., Powrie, F. (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004. (Pubitemid 29480828)
11. Nakamura, K., Kitani, A., Strober, W. (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194, 629-644. (Pubitemid 32844773)
12. Ermann, J., Szanya, V., Ford, G. S., Paragas, V., Fathman, C. G., Lejon, K. (2001) CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. J. Immunol. 167, 4271-4275.
13. Cederbom, L., Hall, H., Ivars, F. (2000) CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538-1543.
14. DiPaolo, R. J., Brinster, C., Davidson, T. S., Andersson, J., Glass, D., Shevach, E. M. (2007) Autoantigen-specific TGFβ-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179, 4685-4693.
15. Mahnke, K., Qian, Y., Knop, J., Enk, A. H. (2003) Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101, 4862-4869.
16. Yamazaki, S., Steinman, R. M. (2009) Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells. J. Dermatol. Sci. 54, 69-75.
17. Dudda, J. C., Perdue, N., Bachtanian, E., Campbell, D. J. (2008) Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205, 1559-1565.
18. Fu, Y. X., Watson, G., Jimenez, J. J., Wang, Y., Lopez, D. M. (1990) Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res. 50, 227-234.
19. Watson, G. A., Fu, Y. X., Lopez, D. M. (1991) Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms. J. Leukoc. Biol. 49, 126-138.
20. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
21. Bronte, V., Zanovello, P. (2005) Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5, 641-654. (Pubitemid 41113195)
22. Liu, C., Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R., Zhang, H. G. (2007) Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109, 4336-4342. (Pubitemid 46743401)
23. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., Ostrand-Rosenberg, S. (2007) Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179, 977-983.
24. Ilkovitch, D., Lopez, D. M. (2009) The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res. 69, 5514-5521.
25. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., Chen, S. H. (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 1123-1131. (Pubitemid 43165981)
26. Youn, J. I., Nagaraj, S., Collazo, M., Gabrilovich, D. I. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802.
27. Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., Rivoltini, L. (2007) Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25, 2546-2553.
28. Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., Montero, A. J. (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 58, 49-59.
29. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689.
30. Kusmartsev, S., Su, Z., Heiser, A., Dannull, J., Eruslanov, E., Kubler, H., Yancey, D., Dahm, P., Vieweg, J. (2008) Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin. Cancer Res. 14, 8270-8278.
31. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., Greten, T. F., Korangy, F. (2008) A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135, 234-243.
32. Haile, L. A., von Wasielewski, R., Gamrekelashvili, J., Kruger, C., Bachmann, O., Westendorf, A. M., Buer, J., Liblau, R., Manns, M. P., Korangy, F., Greten, T. F. (2008) Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135, 871-881.
33. Makarenkova, V. P., Bansal, V., Matta, B. M., Perez, L. A., Ochoa, J. B. (2006) CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176, 2085-2094.
34. Noel, J. G., Osterburg, A., Wang, Q., Guo, X., Byrum, D., Schwemberger, S., Goetzman, H., Caldwell, C. C., Ogle, C. K. (2007) Thermal injury elevates the inflammatory monocyte subpopulation in multiple compartments. Shock 28, 684-693.
35. Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K. M., O'Malley, K. A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., Swan, R., Chung, C. S., Atkinson, M. A., Ramphal, R., Gabrilovich, D. I., Reeves, W. H., Ayala, A., Phillips, J., Laface, D., Heyworth, P. G., Clare-Salzler, M., Moldawer, L. L. (2007) MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463-1474.
36. Dugast, A. S., Haudebourg, T., Coulon, F., Heslan, M., Haspot, F., Poirier, N., Vuillefroy de Silly, R., Usal, C., Smit, H., Martinet, B., Thebault, P., Renaudin, K., Vanhove, B. (2008) Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J. Immunol. 180, 7898-7906.
37. Coquerelle, C., Moser, M. (2010) DC subsets in positive and negative regulation of immunity. Immunol. Rev. 234, 317-334.
38. Steinman, R. M., Hawiger, D., Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
39. Sayed, B. A., Brown, M. A. (2007) Mast cells as modulators of T-cell responses. Immunol. Rev. 217, 53-64. (Pubitemid 46718157)
40. Dunn, G. P., Old, L. J., Schreiber, R. D. (2004) The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329-360.
41. Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., Tosolini, M., Camus, M., Berger, A., Wind, P., Zinzindohoue, F., Bruneval, P., Cugnenc, P. H., Trajanoski, Z., Fridman, W. H., Pages, F. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960-1964.
42. Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., Zheng, Z., Nahvi, A., de Vries, C. R., Rogers-Freezer, L. J., Mavroukakis, S. A., Rosenberg, S. A. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314, 126-129.
43. Ilkovitch, D., Lopez, D. M. (2008) Immune modulation by melanoma-derived factors. Exp. Dermatol. 17, 977-985.
44. McCarter, M. D., Baumgartner, J., Escobar, G. A., Richter, D., Lewis, K., Robinson, W., Wilson, C., Palmer, B. E., Gonzalez, R. (2007) Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients. Ann. Surg. Oncol. 14, 2854-2860.
45. Fujimura, T., Okuyama, R., Ito, Y., Aiba, S. (2008) Profiles of Foxp3+ regulatory T cells in Eczematous dermatitis, Psoriasis vulgaris and Mycosis fungoides. Br. J. Dermatol. 158, 1256-1263.
46. Kaporis, H. G., Guttman-Yassky, E., Lowes, M. A., Haider, A. S., Fuentes-Duculan, J., Darabi, K., Whynot-Ertelt, J., Khatcherian, A., Cardinale, I., Novitskaya, I., Krueger, J. G., Carucci, J. A. (2007) Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J. Invest. Dermatol. 127, 2391-2398.
47. Clark, R. A., Huang, S. J., Murphy, G. F., Mollet, I. G., Hijnen, D., Muthukuru, M., Schanbacher, C. F., Edwards, V., Miller, D. M., Kim, J. E., Lambert, J., Kupper, T. S. (2008) Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J. Exp. Med. 205, 2221-2234.
48. Carroll, R. P., Segundo, D. S., Hollowood, K., Marafioti, T., Clark, T. G., Harden, P. N., Wood, K. J. (2010) Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J. Am. Soc. Nephrol. 21, 713-722.
49. Schatton, T., Schutte, U., Frank, N. Y., Zhan, Q., Hoerning, A., Robles, S. C., Zhou, J., Hodi, F. S., Spagnoli, G. C., Murphy, G. F., Frank, M. H. (2010) Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res. 70, 697-708.
50. Berger, C. L., Tigelaar, R., Cohen, J., Mariwalla, K., Trinh, J., Wang, N., Edelson, R. L. (2005) Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105, 1640-1647. (Pubitemid 40223685)
51. Nagai, H., Horikawa, T., Hara, I., Fukunaga, A., Oniki, S., Oka, M., Nishigori, C., Ichihashi, M. (2004) In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer. Exp. Dermatol. 13, 613-620.
52. Turk, M. J., Guevara-Patino, J. A., Rizzuto, G. A., Engelhorn, M. E., Sakaguchi, S., Houghton, A. N. (2004) Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 200, 771-782.
53. Rasku, M. A., Clem, A. L., Telang, S., Taft, B., Gettings, K., Gragg, H., Cramer, D., Lear, S. C., McMasters, K. M., Miller, D. M., Chesney, J. (2008) Transient T cell depletion causes regression of melanoma metastases. J. Transl. Med. 6, 12.
54. Mahnke, K., Schonfeld, K., Fondel, S., Ring, S., Karakhanova, S., Wiedemeyer, K., Bedke, T., Johnson, T. S., Storn, V., Schallenberg, S., Enk, A. H. (2007) Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. Int. J. Cancer 120, 2723-2733. (Pubitemid 46651297)
55. Prince, H. M., Duvic, M., Martin, A., Sterry, W., Assaf, C., Sun, Y., Straus, D., Acosta, M., Negro-Vilar, A. (2010) Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma. J .Clin. Oncol. 28, 1870-1877.
56. Kimpfler, S., Sevko, A., Ring, S., Falk, C., Osen, W., Frank, K., Kato, M., Mahnke, K., Schadendorf, D., Umansky, V. (2009) Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. J. Immunol. 183, 6330-6337.
57. Nair, S., Boczkowski, D., Fassnacht, M., Pisetsky, D., Gilboa, E. (2007) Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res. 67, 371-380.
58. Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., Rivoltini, L. (2006) Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes. Cancer Res. 66, 9290-9298.
59. Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., Borrello, I. (2004) High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64, 6337-6343.
60. Kaufman, H. L., Kim, D. W., DeRaffele, G., Mitcham, J., Coffin, R. S., Kim-Schulze, S. (2010) Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma. Ann. Surg. Oncol. 17, 718-730.
61. Ilkovitch, D., Lopez, D. M. (2009) Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec. Blood 113, 4729-4739.
62. Stumpfova, M., Ratner, D., Desciak, E. B., Eliezri, Y. D., Owens, D. M. (2010) The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma. Cancer Res. 70, 2962-2972.
63. Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte, V., Borrello, I. (2006) Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J. Exp. Med. 203, 2691-2702.
64. Nagaraj, S., Youn, J. I., Weber, H., Iclozan, C., Lu, L., Cotter, M. J., Meyer, C., Becerra, C. R., Fishman, M., Antonia, S., Sporn, M. B., Liby, K. T., Rawal, B., Lee, J. H., Gabrilovich, D. I. (2010) Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin. Cancer Res. 16, 1812-1823.
65. Bluth, M. J., Zaba, L. C., Moussai, D., Suarez-Farinas, M., Kaporis, H., Fan, L., Pierson, K. C., White, T. R., Pitts-Kiefer, A., Fuentes-Duculan, J., Guttman-Yassky, E., Krueger, J. G., Lowes, M. A., Carucci, J. A. (2009) Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation. J. Invest. Dermatol. 129, 2451-2462.
66. Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J., Enk, A. H. (1999) Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93, 1634-1642.
67. Martinet, L., Poupot, R., Fournie, J. J. (2009) Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies. Immunol. Lett. 124, 1-8.
68. Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., Hayday, A. C. (2001) Regulation of cutaneous malignancy by γδ T cells. Science 294, 605-609.
69. Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., Gottlieb, A. B. (2003) Etanercept as monotherapy in patients with psoriasis. N. Engl. J. Med. 349, 2014-2022.
70. Chan, J. R., Blumenschein, W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S., Lucian, L., Geissler, R., Brodie, S., Kimball, A. B., Gorman, D. M., Smith, K., de Waal Malefyt, R., Kastelein, R. A., McClanahan, T. K., Bowman, E. P. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587.
71. Yawalkar, N., Karlen, S., Hunger, R., Brand, C. U., Braathen, L. R. (1998) Expression of interleukin-12 is increased in psoriatic skin. J. Invest. Dermatol. 111, 1053-1057.
72. Hong, K., Chu, A., Ludviksson, B. R., Berg, E. L., Ehrhardt, R. O. (1999) IL-12, independently of IFN-γ, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J. Immunol. 162, 7480-7491.
73. Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., Lebwohl, M. (2007) A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356, 580-592. (Pubitemid 46220818)
74. Yawalkar, N., Tscharner, G. G., Hunger, R. E., Hassan, A. S. (2009) Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. J. Dermatol. Sci. 54, 99-105.
75. Zaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., Gonzalez, J., Krueger, J. G., Lowes, M. A. (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 129, 79-88.
76. Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y., Blauvelt, A. (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 130, 1373-1383.
77. Zhang, L., Yang, X. Q., Cheng, J., Hui, R. S., Gao, T. W. (2010) Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin. Immunol. 135, 108-117.
78. Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., Cooper, K. D. (2005) Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174, 164-173.
79. Wang, H., Peters, T., Sindrilaru, A., Kess, D., Oreshkova, T., Yu, X. Z., Seier, A. M., Schreiber, H., Wlaschek, M., Blakytny, R., Rohrbein, J., Schulz, G., Weiss, J. M., Scharffetter-Kochanek, K. (2008) TGF-β-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. J. Clin. Invest. 118, 2629-2639.
80. Charles, J., Chaperot, L., Salameire, D., Di Domizio, J., Aspord, C., Gressin, R., Jacob, M. C., Richard, M. J., Beani, J. C., Plumas, J., Leccia, M. T. (2010) Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer. Eur. J. Dermatol. 20, 16-23.
81. Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y. J., Gilliet, M. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J. Exp. Med. 202, 135-143. (Pubitemid 41002916)
82. Albanesi, C., Scarponi, C., Bosisio, D., Sozzani, S., Girolomoni, G. (2010) Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis. Autoimmunity 43, 215-219.
83. Golding, A., Rosen, A., Petri, M., Akhter, E., Andrade, F. (2010) Interferon-α regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses. Immunology, Epub ahead of print.
84. Goodman, W. A., Levine, A. D., Massari, J. V., Sugiyama, H., McCormick, T. S., Cooper, K. D. (2009) IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J. Immunol. 183, 3170-3176.
85. Fletcher, J. M., Lonergan, R., Costelloe, L., Kinsella, K., Moran, B., O'Farrelly, C., Tubridy, N., Mills, K. H. (2009) CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J. Immunol. 183, 7602-7610.
86. Yan, K. X., Fang, X., Han, L., Zhang, Z. H., Kang, K. F., Zheng, Z. Z., Huang, Q. (2010) Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque versus Guttate psoriasis vulgaris. Br. J. Dermatol. 163, 48-56.
87. Quaglino, P., Ortoncelli, M., Comessatti, A., Ponti, R., Novelli, M., Bergallo, M., Costa, C., Cicchelli, S., Savoia, P., Bernengo, M. G. (2009) Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology 219, 250-258.
88. Saito, C., Maeda, A., Morita, A. (2009) Bath-PUVA therapy induces circulating regulatory T cells in patients with psoriasis. J. Dermatol. Sci. 53, 231-233.
89. Werfel, T. (2009) The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J. Invest. Dermatol. 129, 1878-1891.
90. Girardi, M., Lewis, J., Glusac, E., Filler, R. B., Geng, L., Hayday, A. C., Tigelaar, R. E. (2002) Resident skin-specific γδ T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195, 855-867. (Pubitemid 34286757)
91. Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., Tokura, Y. (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128, 2625-2630.
92. Cavani, A., Nasorri, F., Ottaviani, C., Sebastiani, S., De Pita, O., Girolomoni, G. (2003) Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J. Immunol. 171, 5760-5768. (Pubitemid 37467191)
93. Ring, S., Schafer, S. C., Mahnke, K., Lehr, H. A., Enk, A. H. (2006) CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur. J. Immunol. 36, 2981-2992. (Pubitemid 44782572)
94. Halabi-Tawil, M., Ruemmele, F. M., Fraitag, S., Rieux-Laucat, F., Neven, B., Brousse, N., De Prost, Y., Fischer, A., Goulet, O., Bodemer, C. (2009) Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br. J. Dermatol. 160, 645-651.
95. Ou, L. S., Goleva, E., Hall, C., Leung, D. Y. (2004) T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J. Allergy Clin. Immunol. 113, 756-763. (Pubitemid 38530433)
96. McLachlan, J. B., Catron, D. M., Moon, J. J., Jenkins, M. K. (2009) Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity 30, 277-288.
97. Cardona, I. D., Goleva, E., Ou, L. S., Leung, D. Y. (2006) Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J. Allergy Clin. Immunol. 117, 688-695. (Pubitemid 43340237)
98. Martin, S. F., Dudda, J. C., Bachtanian, E., Lembo, A., Liller, S., Durr, C., Heimesaat, M. M., Bereswill, S., Fejer, G., Vassileva, R., Jakob, T., Freudenberg, N., Termeer, C. C., Johner, C., Galanos, C., Freudenberg, M. A. (2008) Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J. Exp. Med. 205, 2151-2162.
99. Jin, H., Kumar, L., Mathias, C., Zurakowski, D., Oettgen, H., Gorelik, L., Geha, R. (2009) Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. J. Allergy Clin. Immunol. 123, 875-882.
100. Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., Horton, M. R. (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272-1281. (Pubitemid 44036633)
101. Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., Homer, R. J., Goldstein, D. R., Bucala, R., Lee, P. J., Medzhitov, R., Noble, P. W. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173-1179.
102. Oberg, H. H., Ly, T. T., Ussat, S., Meyer, T., Kabelitz, D., Wesch, D. (2010) Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands. J. Immunol. 184, 4733-4740.
103. Barlow, S. C., Xu, H., Weaver, C. T., Lindsey, J. R., Schoeb, T. R., Bullard, D. C. (2004) Development of dermatitis in CD18-deficient PL/J mice is not dependent on bacterial flora, and requires both CD4+ and CD8+ T lymphocytes. Int. Immunol. 16, 345-351. (Pubitemid 38195665)
104. Scharffetter-Kochanek, K., Lu, H., Norman, K., van Nood, N., Munoz, F., Grabbe, S., McArthur, M., Lorenzo, I., Kaplan, S., Ley, K., Smith, C. W., Montgomery, C. A., Rich, S., Beaudet, A. L. (1998) Spontaneous skin ulceration and defective T cell function in CD18 null mice. J. Exp. Med. 188, 119-131.
105. Ring, S., Oliver, S. J., Cronstein, B. N., Enk, A. H., Mahnke, K. (2009) CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism. J. Allergy Clin. Immunol. 123, 1287-1296.
106. Kwon, H. K., Lee, C. G., So, J. S., Chae, C. S., Hwang, J. S., Sahoo, A., Nam, J. H., Rhee, J. H., Hwang, K. C., Im, S. H. (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. USA 107, 2159-2164.
107. Brandt, C., Pavlovic, V., Radbruch, A., Worm, M., Baumgrass, R. (2009) Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy 64, 1588-1596.
108. Yanaba, K., Bouaziz, J. D., Haas, K. M., Poe, J. C., Fujimoto, M., Tedder, T. F. (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639-650.
109. Kaplan, D. H., Jenison, M. C., Saeland, S., Shlomchik, W. D., Shlomchik, M. J. (2005) Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23, 611-620. (Pubitemid 41779483)
110. Igyarto, B. Z., Jenison, M. C., Dudda, J. C., Roers, A., Muller, W., Koni, P. A., Campbell, D. J., Shlomchik, M. J., Kaplan, D. H. (2009) Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and Langerhans cell-derived IL-10. J. Immunol. 183, 5085-5093.
111. Yoshiki, R., Kabashima, K., Sugita, K., Atarashi, K., Shimauchi, T., Tokura, Y. (2009) IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. J. Invest. Dermatol. 129, 705-713.
112. Bennett, C. L., van Rijn, E., Jung, S., Inaba, K., Steinman, R. M., Kapsenberg, M. L., Clausen, B. E. (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169, 569-576. (Pubitemid 41002850)
113. Streilein, J. W., Grammer, S. F., Yoshikawa, T., Demidem, A., Vermeer, M. (1990) Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes. Immunol. Rev. 117, 159-183. (Pubitemid 20353336)
114. Wang, L., Bursch, L. S., Kissenpfennig, A., Malissen, B., Jameson, S. C., Hogquist, K. A. (2008) Langerin expressing cells promote skin immune responses under defined conditions. J. Immunol. 180, 4722-4727.
115. Kaplan, D. H., Kissenpfennig, A., Clausen, B. E. (2008) Insights into Langerhans cell function from Langerhans cell ablation models. Eur. J. Immunol. 38, 2369-2376.
116. Marhaba, R., Vitacolonna, M., Hildebrand, D., Baniyash, M., Freyschmidt-Paul, P., Zoller, M. (2007) The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J. Immunol. 179, 5071-5081.
117. Schwacha, M. G., Somers, S. D. (1998) Thermal injury-induced immunosuppression in mice: the role of macrophage-derived reactive nitrogen intermediates. J. Leukoc. Biol. 63, 51-58.
118. Noel, J. G., Guo, X., Wells-Byrum, D., Schwemberger, S., Caldwell, C. C., Ogle, C. K. (2005) Effect of thermal injury on splenic myelopoiesis. Shock 23, 115-122.
119. Schwacha, M. G., Thobe, B. M., Daniel, T., Hubbard, W. J. (2010) Impact of thermal injury on wound infiltration and the dermal inflammatory response. J. Surg. Res. 158, 112-120.
120. Kobayashi, M., Yoshida, T., Takeuchi, D., Jones, V. C., Shigematsu, K., Herndon, D. N., Suzuki, F. (2008) Gr-1(+)CD11b(+) cells as an accelerator of sepsis stemming from Pseudomonas aeruginosa wound infection in thermally injured mice. J. Leukoc. Biol. 83, 1354-1362.
121. Murphy, T. J., Ni Choileain, N., Zang, Y., Mannick, J. A., Lederer, J. A. (2005) CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J. Immunol. 174, 2957-2963.
122. Huang, L. F., Yao, Y. M., Zhang, L. T., Dong, N., Yu, Y., Sheng, Z. Y. (2009) The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock 31, 322-329.
123. Ni Choileain, N., MacConmara, M., Zang, Y., Murphy, T. J., Mannick, J. A., Lederer, J. A. (2006) Enhanced regulatory T cell activity is an element of the host response to injury. J. Immunol. 176, 225-236.
124. D'Arpa, N., Accardo-Palumbo, A., Amato, G., D'Amelio, L., Pileri, D., Cataldo, V., Mogavero, R., Lombardo, C., Napoli, B., Conte, F. (2009) Circulating dendritic cells following burn. Burns 35, 513-518.
125. Lechler, R., Ng, W. F., Steinman, R. M. (2001) Dendritic cells in transplantation - friend or foe? Immunity 14, 357-368.
126. Adeegbe, D., Bayer, A. L., Levy, R. B., Malek, T. R. (2006) Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J. Immunol. 176, 7149-7153.
127. Adeegbe, D., Levy, R. B., Malek, T. R. (2010) Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance. Blood 115, 1932-1940.
128. Wang, X. N., Haniffa, M. A., Holtick, U., Collin, M. P., Jackson, G., Hilkens, C. M., Holler, E., Edinger, M., Hoffmann, P., Dickinson, A. M. (2009) Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming. Transplantation 88, 188-197.
129. Lu, L. F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., Strom, T. B., Zheng, X. X., Noelle, R. J. (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997-1002.
130. Zhang, W., Liang, S., Wu, J., Horuzsko, A. (2008) Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86, 1125-1134.
131. De Wilde, V., Van Rompaey, N., Hill, M., Lebrun, J. F., Lemaitre, P., Lhomme, F., Kubjak, C., Vokaer, B., Oldenhove, G., Charbonnier, L. M., Cuturi, M. C., Goldman, M., Le Moine, A. (2009) Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am. J. Transplant. 9, 2034-2047.
132. Obhrai, J. S., Oberbarnscheidt, M., Zhang, N., Mueller, D. L., Shlomchik, W. D., Lakkis, F. G., Shlomchik, M. J., Kaplan, D. H. (2008) Langerhans cells are not required for efficient skin graft rejection. J. Invest. Dermatol. 128, 1950-1955.
133. Chakraverty, R., Cote, D., Buchli, J., Cotter, P., Hsu, R., Zhao, G., Sachs, T., Pitsillides, C. M., Bronson, R., Means, T., Lin, C., Sykes, M. (2006) An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J. Exp. Med. 203, 2021-2031.
134. Hill, G. R., Olver, S. D., Kuns, R. D., Varelias, A., Raffelt, N. C., Don, A. L., Markey, K. A., Wilson, Y. A., Smyth, M. J., Iwakura, Y., Tocker, J., Clouston, A. D., Macdonald, K. P. (2010) Stem cell mobilization with G-CSF induces type-17 differentiation and promotes scleroderma. Blood, Epub ahead of print.